These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6992450)

  • 1. [Therapeutic action of pyrimidine derivatives in liver diseases (a review of the literature)].
    Rychnev VE; Frolov VM
    Vrach Delo; 1980 Apr; (4):58-61. PubMed ID: 6992450
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of pentoxyl and methyluracil (methacil) in liver diseases (literature review)].
    Vitlin VI
    Klin Khir (1962); 1971 Mar; 3():71-5. PubMed ID: 4941177
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of folinic acid on various experimental hepatopathies in rats].
    Ramacci MT; Ordoñez ET
    Clin Ter; 1970 May; 53(3):227-34. PubMed ID: 5311582
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapy of hepatic diseases in ambulatory medicine. Multicenter studies].
    Martines G; Mingrino GC; Cagnetta G; Copponi V
    Clin Ter; 1980 Jan; 92(1):33-58. PubMed ID: 7449307
    [No Abstract]   [Full Text] [Related]  

  • 5. [Silymarin, a membranotropic drug: clinical and experimental observations].
    De Martiis M; Fontana M; Sebastiani F; Parenzi A
    Clin Ter; 1977 May; 81(4):333-62. PubMed ID: 880785
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experiences with Vitamin B-12 therapy of chronic liver diseases in a resort practice].
    André W
    Munch Med Wochenschr; 1966 Mar; 108(11):610-1. PubMed ID: 6013869
    [No Abstract]   [Full Text] [Related]  

  • 7. [Metabolism pathways and use of heptral in chronic liver diseases].
    Il'chenko LIu; Vinnitskaia EV
    Eksp Klin Gastroenterol; 2002; (2):62-4, 103. PubMed ID: 12046390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical and experimental study of shuangcao tuihuang granule-1 in treating severe jaundice of acute icterohepatitis].
    Lian YX; Long XY; Wu WF
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2001 Sep; 21(9):649-51. PubMed ID: 12575547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of liver disease with corticosteroids.
    Lesesne HR; Fallon HJ
    Med Clin North Am; 1973 Sep; 57(5):1191-201. PubMed ID: 4593197
    [No Abstract]   [Full Text] [Related]  

  • 10. [Silymarin action in liver diseases].
    Hammerl H; Pichler O; Studlar M
    Med Klin; 1971 Sep; 66(36):1204-8. PubMed ID: 5096207
    [No Abstract]   [Full Text] [Related]  

  • 11. Medical evaluation of the patient with liver disease prior to surgery.
    Blundell CR; Earnest DL
    Contemp Anesth Pract; 1981; 4():123-69. PubMed ID: 7014090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malotilate: the new hope for a clinically effective agent for the treatment of liver disease.
    Ryle PR; Dumont JM
    Alcohol Alcohol; 1987; 22(2):121-41. PubMed ID: 3307796
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of extracellular vesicles in liver diseases and their therapeutic potential.
    Kostallari E; Valainathan S; Biquard L; Shah VH; Rautou PE
    Adv Drug Deliv Rev; 2021 Aug; 175():113816. PubMed ID: 34087329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Reflections on prednisone therapy of patients with liver diseases].
    Teichmann W
    Dtsch Z Verdau Stoffwechselkr; 1970; 30(1):25-7. PubMed ID: 5501421
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti-apoptotic therapeutic approaches in liver diseases: do they really make sense?
    Bannert K; Kuhla A; Abshagen K; Vollmar B
    Apoptosis; 2014 Aug; 19(8):1243-53. PubMed ID: 24872082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Azathioprine and hepatic functional structures (clinical and experimental studies)].
    Nicolaescu T; Bittman E; Stoiculescu P; Bordeianu A; Ciontescu L
    Rev Roum Physiol; 1973; 10(4):281-7. PubMed ID: 4353104
    [No Abstract]   [Full Text] [Related]  

  • 17. Differential diagnosis, laboratory tests and histology in 245 patients with cholestasis.
    Stajić M; Milosavljević J; Begić-Janev A
    Acta Hepatogastroenterol (Stuttg); 1979 Oct; 26(5):375. PubMed ID: 525215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatotropic therapy in treatment of liver injury].
    Sukhanov DS; Okovityĭ SV; Iablonskiĭ PK; Vinogradova TI; Pavlova MV
    Antibiot Khimioter; 2012; 57(5-6):41-52. PubMed ID: 23156043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antibiotic use and toxicity in liver diseases].
    Siutkin VE; Ivanikov IO
    Eksp Klin Gastroenterol; 2002; (2):65-7. PubMed ID: 12046391
    [No Abstract]   [Full Text] [Related]  

  • 20. Methotrexate treatment of chronic cholestatic liver diseases: friend or foe?
    Kaplan MM
    Q J Med; 1989 Aug; 72(268):757-61. PubMed ID: 2532375
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.